Halliburton Labs has announced its next set of clean energy tech companies. Photo courtesy of Halliburton

Three climatetech companies will be joining Halliburton Labs, a Houston-based energy transition incubator.

Chemergy, EVA, and Novamera will be joining Halliburton Labs, the company announced last week. The three startups will receive technical support, access to Halliburton's global connections, and more from the program.

“We are excited to help accelerate three innovative companies that emerged from our recent Finalists Pitch Day,” says Dale Winger, managing director of Halliburton Labs, in a news release. “We will work closely with these founders and their teams to achieve strategic, operational, and financial milestones with the most efficient use of their time and capital."

Halliburton Labs launched in the summer of 2020, and now has over a dozen companies working on climatetech solutions in its portfolio. Applications are now open for the next cohort on the Halliburton Labs website and are due by April 22, for the May 20 Finalists Pitch Day.

"In less than two years, we've established productive new relationships with fifteen companies scaling solutions across a breadth of markets to expand our understanding of new value chains,” Winger continues.

Here's a little more about the three new additions to the program.

Chemergy 

Miami-based Chemergy has created a patented HyBrTec process is designed to convert wet organic and plastic wastes into green hydrogen, thereby eliminating the liability and consequences of the wastes by converting them into fuel.

“We see a great opportunity to collaborate with Halliburton Labs' industrial experience to ensure our systems can be installed and operated safely in communities to solve waste disposal issues, improve resiliency and sustainability, and produce cleaner fuel locally,” says Melahn Parker, president of Chemergy.

EVA 

EVA, a New York headquartered company with a presence on four continents, is increasing scalability for the drone industry with its ground infrastructure and operating system solutions that help customers perform inspections, make deliveries, recharge, and monitor remote operations without local manpower.

“The Halliburton Labs ‘scalerator' model comes at the right time for EVA as we accelerate commercialization," says Olivier Le Lann, founder and CEO. "We're excited about the ways Halliburton's global market and industrial expertise will accelerate our trajectory."

Novamera 

Canadian company Novamera has developed proprietary navigation tools and software that enables climate smart, surgical mining and unlocks value in certain mineral deposits found worldwide that are otherwise uneconomic due to their small scale and geometry.

“We are pleased to join Halliburton Labs' accelerator program," says Novamera Co-founder and CEO Dustin Angelo in a news release. "Their engineering expertise and business experience will help us accelerate the development of our technology and scale our business to bring a more sustainable method of mining to the world.”

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Austin company to bring AI-powered school to The Woodlands

AI education

Austin-based Alpha School, which operates AI-powered private schools, is opening its first Houston-area location in The Woodlands.

The 8,000-square-foot school, scheduled to be ready for the 2026-27 academic year, initially will serve students in kindergarten through eighth grade. Alpha says the school will offer “open workshop spaces and innovative classrooms that support personalized instruction, core academics, leadership development, and real-world life skills.”

Alpha sets aside two hours each school day for the AI-driven, self-paced study of core subjects like math, reading and science. The rest of each school day consists of life-skills workshops focusing on topics such as leadership and financial literacy.

Alpha’s school in The Woodlands has begun accepting applications for the 2026-27 school year. Annual tuition costs $40,000.

“The Woodlands is one of the most dynamic, forward-thinking communities in Texas, and Alpha is proud to bring

an innovative educational model that complements its strong academic foundation,” says Rachel Goodlad, head

of expansion for Alpha.

Founded in 2014, Alpha School combines adaptive technology-driven instruction with immersive life-skills workshops. Its model emphasizes mastery-based learning in core subjects alongside development of communication, critical thinking, financial literacy and leadership skills. It operates more than 15 schools across the country.

Elsewhere in Texas, Alpha operates schools in Austin, Brownsville, Fort Worth and Plano. Alpha also operates 12 Texas Sports Academy campuses in Texas, including locations in Houston, Pearland and Richmond, along with a NextGen Academy esports school in Austin, a school for gifted students in Georgetown, and lower-cost Nova Academy campuses in Austin and Bastrop.

Alpha has fans and critics. While supporters tout students’ high achievement rates, detractors complain about the high tuition and the AI-influenced depersonalization of education.

“Students and our country need to be in relationship with other human beings,” Randi Weingarten, president of the American Federation of Teachers, a teachers union, tells The New York Times. “When you have a school that is strictly AI, it is violating that core precept of the human endeavor and of education.”

Alpha co-founder MacKenzie Price, a podcaster and social media influencer, doesn’t share Weingarten’s views.

“Parents and teachers: We need to embrace this change,” Price wrote after President Trump signed an executive order promoting AI in schools.

The Times notes that Alpha doesn’t employ AI as a tutor or a supplement. Rather, the newspaper says, AI is “the school’s primary educational driver to move students through academic content.”

Houston researcher secures $1.7M to develop drug for aggressive form of breast cancer

cancer research

A University of Houston researcher has joined a $3.2 million effort to develop a new drug designed to attack a cancer-driving protein commonly found in triple-negative breast cancer.

Triple-negative breast cancer (TNBC) is one of the most difficult-to-treat forms of cancer and accounts for 10 percent to 15 percent of all breast cancer cases. The disease gets its name because tumors associated with it test negative for estrogen receptors, progesterone receptors and excess HER2 protein, making it difficult to target. Due to this, TNBC is often treated with general chemotherapy, which can come with negative side effects and drug resistance, according to UH.

UH College of Pharmacy research associate professor Wei Wang is developing a drug that can target the disease more specifically. The drug will target MDM2, a protein often overproduced in TNBC that also contributes to faster tumor growth.

Wang is working on a team led by Wei Li, director of the University of Tennessee Health Science Center College of Pharmacy’s Drug Discovery Center. She has received $1.7 million to support the research.

Wang and UH professor of pharmacology and toxicology Ruiwen Zhang have discovered a compound that can break down MDM2. In early laboratory models, the compound has shown the ability to shrink tumors.

Wang and Zhang will focus on understanding how the treatment works and monitoring its effectiveness in models that closely mirror human disease.

“We will study how the drug targets MDM2 and evaluate the most promising drug candidates to determine effective dosing, understand how the drug behaves in the body, compare it with existing treatments and assess early safety,” Wang said in a news release.

Li’s team at the University of Tennessee will be working on the chemistry and drug design end of the project.

“This work could lead to an entirely new class of therapies for triple-negative breast cancer,” Li added in the release. “We’re hopeful that by directly removing the MDM2 protein from cancer cells, we can help more patients respond to treatment regardless of their tumor type.”